Designing of novel ERRĪ³ inverse agonists by molecular modeling studies of docking and 3D-QSAR on hydroxytamoxifen derivatives
Crossref DOI link: https://doi.org/10.1007/s00044-019-02402-9
Published Online: 2019-08-13
Published Print: 2019-10-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Rui
Du, Yongli
Shen, Jingkang
Text and Data Mining valid from 2019-08-13
Version of Record valid from 2019-08-13
Article History
Received: 26 March 2019
Accepted: 16 July 2019
First Online: 13 August 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.